| __timestamp | Amphastar Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 23138050 |
| Thursday, January 1, 2015 | 37065000 | 57410147 |
| Friday, January 1, 2016 | 41199000 | 41454452 |
| Sunday, January 1, 2017 | 43415000 | 31690298 |
| Monday, January 1, 2018 | 57564000 | 52968505 |
| Tuesday, January 1, 2019 | 68853000 | 81048686 |
| Wednesday, January 1, 2020 | 67229000 | 128874979 |
| Friday, January 1, 2021 | 60932000 | 206342000 |
| Saturday, January 1, 2022 | 74771000 | 297307000 |
| Sunday, January 1, 2023 | 73741000 | 353188000 |
| Monday, January 1, 2024 | 505870000 |
Unleashing insights
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Arrowhead's R&D expenses surged by over 1,400%, reflecting its commitment to pioneering new treatments. In contrast, Amphastar's R&D spending grew by approximately 160%, indicating a more measured approach.
These trends highlight the strategic differences between the two companies, with Arrowhead aggressively pursuing innovation, while Amphastar maintains a steady course. Missing data for 2024 suggests ongoing developments in the field.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
Corcept Therapeutics Incorporated or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Arrowhead Pharmaceuticals, Inc. and Novavax, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.